England's cancer drugs fund 'failed to deliver meaningful value to patients and society'
Saturday, April 29, 2017 - 08:31
in Health & Medicine
Analysis of the drugs that were approved for use by the NHS Cancer Drugs Fund (CDF) in England has shown that the fund was not good value for patients and society and may have resulted in patients suffering unnecessarily from toxic side effects of the drugs.